Healthcare - Genomics & Precision Medicine
Companies in gene therapy, genetic testing, and personalized medicine platforms
Gene Therapy & Gene Editing60
RNA Therapeutics10
Genetic Testing & Diagnostics23
Precision Medicine Platforms49
| Ticker | Company | Sub-Theme | Mkt Cap▼ | Price | Chg% | Volume |
|---|---|---|---|---|---|---|
 AZN | AstraZeneca PLC | Precision Medicine Platforms | $300.7b | $204.13 | +0.3% | 221.8K |
 TMO | Thermo Fisher Scientific, Inc. | Precision Medicine Platforms | $178.3b | $486.25 | -1.1% | 438.3K |
 DHR | Danaher Corporation | Precision Medicine Platforms | $130.1b | $191.38 | +0.1% | 567.9K |
 VRTX | Vertex Pharmaceuticals Inc | Gene Therapy & Gene Editing | $112.6b | $440.14 | +0.3% | 133.0K |
 REGN | Regeneron Pharmaceuticals Inc | Gene Therapy & Gene Editing | $79.2b | $766.47 | +0.6% | 87.3K |
 ALNY | Alnylam Pharmaceuticals, Inc. | RNA Therapeutics | $41.9b | $330.15 | +3.5% | 391.0K |
 INSM | Insmed, Inc. | Gene Therapy & Gene Editing | $33.0b | $164.40 | +1.2% | 305.8K |
 WAT | Waters Corp | Precision Medicine Platforms | $28.8b | $303.80 | -0.1% | 114.7K |
 NTRA | Natera, Inc. Common Stock | Genetic Testing & Diagnostics | $26.5b | $204.75 | -1.6% | 188.1K |
 LH | Labcorp Holdings Inc. | Genetic Testing & Diagnostics | $21.7b | $275.28 | +0.6% | 121.5K |
 ILMN | Illumina Inc | Genetic Testing & Diagnostics | $18.5b | $127.63 | +0.2% | 284.9K |
 BBIO | BridgeBio Pharma, Inc. Common Stock | Precision Medicine Platforms | $13.4b | $73.31 | +0.2% | 82.9K |
 IONS | Ionis Pharmaceuticals, Inc. Common Stock | RNA Therapeutics | $12.0b | $74.80 | +0.0% | 179.5K |
 GH | Guardant Health, Inc. Common Stock | Precision Medicine Platforms | $11.3b | $90.68 | -3.4% | 244.0K |
 BMRN | BioMarin Pharmaceuticals Inc | Gene Therapy & Gene Editing | $10.5b | $55.85 | +0.6% | 242.5K |
 RVTY | Revvity, Inc. | Precision Medicine Platforms | $9.5b | $87.73 | -1.4% | 112.6K |
 TECH | Bio-Techne Corp. | Precision Medicine Platforms | $8.1b | $53.16 | +0.1% | 411.1K |
 QGEN | QIAGEN N.V. | Genetic Testing & Diagnostics | $8.1b | $40.74 | -0.7% | 153.0K |
 ARWR | Arrowhead Research Corporation | RNA Therapeutics | $8.1b | $61.60 | +0.9% | 218.7K |
 PRAX | Praxis Precision Medicines, Inc. Common Stock | Precision Medicine Platforms | $7.7b | $318.28 | +2.5% | 76.5K |
 NUVL | Nuvalent, Inc. Class A Common Stock | Precision Medicine Platforms | $7.6b | $103.63 | -1.7% | 150.6K |
 TEM | Tempus AI, Inc. Class A Common Stock | Precision Medicine Platforms | $7.6b | $47.67 | +0.6% | 994.7K |
 KRYS | Krystal Biotech, Inc. Common Stock | Gene Therapy & Gene Editing | $7.2b | $265.05 | +1.6% | 138.7K |
 KYMR | Kymera Therapeutics, Inc. Common Stock | Precision Medicine Platforms | $6.5b | $84.55 | -1.0% | 65.5K |
 CAI | Caris Life Sciences, Inc. Common Stock | Precision Medicine Platforms | $4.8b | $19.38 | +0.5% | 270.3K |
 LNTH | Lantheus Holdings, Inc | Precision Medicine Platforms | $4.8b | $75.87 | -0.3% | 71.0K |
 FOLD | Amicus Therapeutics, Inc | Gene Therapy & Gene Editing | $4.5b | $14.45 | +0.0% | 234.7K |
 CRSP | CRISPR Therapeutics AG | Gene Therapy & Gene Editing | $4.3b | $50.12 | +1.2% | 225.4K |
 BLLN | BillionToOne, Inc. Class A Common Stock | Genetic Testing & Diagnostics | $3.2b | $82.89 | +4.4% | 78.0K |
 DYN | Dyne Therapeutics, Inc. Common Stock | Precision Medicine Platforms | $2.8b | $18.78 | -0.3% | 275.2K |
 IDYA | IDEAYA Biosciences, Inc. Common Stock | Precision Medicine Platforms | $2.8b | $32.88 | +0.4% | 108.8K |
 TWST | Twist Bioscience Corporation Common Stock | Precision Medicine Platforms | $2.7b | $51.30 | +2.2% | 139.8K |
 TXG | 10x Genomics, Inc. Class A Common Stock | Genetic Testing & Diagnostics | $2.5b | $22.34 | +0.0% | 637.1K |
 VCYT | Veracyte, Inc. | Genetic Testing & Diagnostics | $2.4b | $32.17 | -0.3% | 77.4K |
 BEAM | Beam Therapeutics Inc. Common Stock | Gene Therapy & Gene Editing | $2.2b | $24.89 | +0.9% | 324.2K |
 SRPT | Sarepta Therapeutics,, Inc. Common Stock | Gene Therapy & Gene Editing | $2.2b | $23.26 | +0.1% | 484.1K |
 ADPT | Adaptive Biotechnologies Corporation Common Stock | Precision Medicine Platforms | $2.0b | $14.49 | -2.2% | 210.9K |
 WGS | GeneDx Holdings Corp. Class A Common Stock | Genetic Testing & DiagnosticsPrecision Medicine Platforms | $1.7b | $67.05 | +1.3% | 87.8K |
 VCEL | Vericel Corporation | Gene Therapy & Gene Editing | $1.6b | $34.34 | +0.6% | 102.7K |
 MAZE | Maze Therapeutics, Inc. Common Stock | Precision Medicine Platforms | $1.4b | $28.80 | +0.3% | 122.2K |
 NTLA | Intellia Therapeutics, Inc | Gene Therapy & Gene Editing | $1.4b | $13.55 | +3.2% | 606.9K |
 WVE | Wave Life Sciences Ltd. Ordinary Shares | RNA Therapeutics | $1.2b | $7.38 | +1.3% | 705.3K |
 TSHA | Taysha Gene Therapies, Inc. Common Stock | Gene Therapy & Gene Editing | $1.2b | $4.68 | +7.2% | 2.2M |
 PGEN | Precigen, Inc. Common Stock | Gene Therapy & Gene Editing | $1.2b | $4.13 | +4.9% | 1.1M |
 PCRX | Pacira BioSciences, Inc. Common Stock | Gene Therapy & Gene Editing | $0.9b | $22.67 | -0.1% | 67.0K |
 NEO | NeoGenomics, Inc. | Genetic Testing & Diagnostics | $0.9b | $8.04 | +0.4% | 283.2K |
 AZTA | Azenta, Inc. | Genetic Testing & Diagnostics | $0.9b | $22.69 | +0.3% | 139.1K |
 QURE | uniQure N.V. | Gene Therapy & Gene Editing | $0.9b | $17.41 | +1.5% | 236.6K |
 BLFS | BioLife Solutions Inc. | Gene Therapy & Gene Editing | $0.9b | $19.30 | -1.1% | 34.2K |
 CDNA | CareDx, Inc. | Genetic Testing & DiagnosticsPrecision Medicine Platforms | $0.8b | $18.24 | -0.4% | 54.4K |